ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "CD20"

  • 2020 American Transplant Congress

    B Cell Depletion with Anti-CD20 mAb Exacerbates Anti-Donor CD4+ T Cell Responses in Highly Sensitized Transplant Model

    A. Tanaka, K. Ide, Y. Tanaka, M. Ohira, H. Tahara, H. Morimoto, H. Ohdan

    Gastroenterological and Transplant Surgery, Hiroshima University, Hiroshima, Japan

    *Purpose: Preformed donor-specific anti-human leukocyte antigen antibodies (DSAs) have been associated with detrimental effects in transplant recipients. To eliminate preformed DSAs, we desensitized DSA-positive recipients…
  • 2019 American Transplant Congress

    Efficacy Of Rituximab Monotherapy On Anti-human Leukocyte Antigen Antibodies In Highly Sensitized Living Donor Kidney Transplant Patients.

    D. J. Sindi1, A. Al Jedai2, H. Aleid3, J. Brockmann4, M. Al-Awwami5, D. Alissa2, E. De Vol6, H. Al Khabbaz7, L. Fajji8

    1Clinical Pharmacy, King Faisal Specialist Hospital and Research Center (KFSH&RC), Riyadh, Saudi Arabia, 2Clinical Pharmacy, KFSH&RC, Riyadh, Saudi Arabia, 3Kidney and Pancreas transplantation, KFSH&RC, Riyadh, Saudi Arabia, 4kFSH&RC, Riyadh, Saudi Arabia, 5Clinical Director, Histocompatibility and Immunogenetics Laboratory, KFSH&RC, Riyadh, Saudi Arabia, 6KFSH&RC, Riyadh, Saudi Arabia, 7Riyadh Elm University, Riyadh, Saudi Arabia, 8Clinical Transplant Coordinator, KFSH&RC, Riyadh, Saudi Arabia

    *Purpose: We aim to examine the efficacy of Rituximab (RTX) monotherapy in reducing DSA in Highly Sensitised Living Donor Kidney Transplant (HS-LDKT) candidates and potentially…
  • 2019 American Transplant Congress

    Variable Outcomes of Recurrent Autoimmune Diabetes Post Pancreas Transplant Treated with Rituximab

    K. Venkatachalam, A. Markwardt, B. Heady, T. Alhamad, A. Malone

    Washington University, St. Louis, MO

    *Purpose: Demonstrate the outcomes of treatment with rituximab in patients with autoimmune diabetes after pancreas transplant.*Methods: We present the treatment response to rituximab in 3…
  • 2018 American Transplant Congress

    The Incidence of Polyomavirus-BK and Cytomegalovirus Infections in Renal Transplant Recipients Following Rituximab Administration

    A. Kraljevic, C. D'Agostino, C. Kane, K. Cunningham, A. Shetty, C. Richardson.

    Northwestern Memorial Hospital, Chicago, IL.

    Rituximab is an antibody that binds to the CD20 antigen on B cells resulting in rapid and prolonged depletion. At Northwestern Memorial Hospital, a single…
  • 2018 American Transplant Congress

    Evaluation of FlowDSA Crossmatch for Detection of Donor-Specific HLA Antibodies

    J. Lee, J. Ryu, A. Choi, E-.J. Oh.

    Laboratory Medicine, Seoul St. Mary's Hospital, the Catholic University of Korea, Seoul, Republic of Korea.

    Background: Donor-specific HLA antibodies (DSA) are detected by different crossmatch techniques. Flow cytometric crossmatching (FCXM) is sensitive method, but it is subject to false (+)…
  • 2018 American Transplant Congress

    CD19+ Cell Ratio as a Predictive Marker of Antibody Mediated Rejection in ABO Incompatible Kidney Transplantation

    K. Unagami,1 R. Maenosono,2 M. Furusawa,2 Y. Kakuta,2 M. Okumi,2 H. Ishida,2 K. Tanabe,2 K. Nitta.1

    1Nephrology, Tokyo Women's Medical University, Tokyo, Japan; 2Urology, Tokyo Women's Medical University, Tokyo, Japan.

    Background: Rituximab has been suggested to deplete B cells and decrease the possibility of antibody mediated rejection (AMR) in ABO-incompatible living kidney transplantation (ABO-ILKT). We…
  • 2018 American Transplant Congress

    B-Cell Depletion with Rituximab Exacerbates Anti-Donor CD4+ T-Cell Responses in Patients with Donor-Specific Anti-Human Leukocyte Antigen Antibodies

    A. Tanaka, K. Ide, Y. Tanaka, M. Ohira, H. Tahara, S. Shimizu, H. Ohdan.

    Gastroenterological and Transplant Surgery, Hiroshima University, Hiroshima, Japan.

    Background: It has been reported that preformed donor-specific anti-human leukocyte antigen antibodies (DSAs) were associated with poor graft outcomes in kidney transplant recipients. To eliminate…
  • 2018 American Transplant Congress

    Pretransplant Use of Rituximab is Associated with Posttransplant Malignancies Events and Death by Neoplasia in Incompatibility Living Donor Kidney Transplants

    I. Revuelta,1,2,3,4 V. Tubita,2 D. Cucchiari,1,2 E. De Sousa,1 P. Piselli,5 M. Lozano,6 J. Cid,6 E. Palou,7 J. Martorell,7 F. Oppenheimer,1,2,3,4 F. Diekmann,1,2,3,4 J. Campistol.1,2,3,4

    1Renal Transplant Unit. Department of Nephrology and Kidney Transplant. Hospital Clinic, Barcelona, Spain; 2Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; 3REDINREN, Madrid, Spain; 4Barcelona University, Barcelona, Spain; 5Dipartamento di Epidemiologia e Ricerca Pre-Clinica. IRCCC, Roma, Italy; 6Department of Apheresis. Hospital Clinic, Barcelona, Spain; 7Department of Immunology. Hospital Clinic, Barcelona, Spain.

    Introduction: Incompatibilities is a challenge in kidney transplantation. Potent immunosuppression approach based on desensitization protocols (DS) are usually needed; However, controversies in results and lack…
  • 2018 American Transplant Congress

    Absence of Rejection in a Facial Allograft Recipient with a Postive Flow Crossmatch 24 Months after Induction with Rabbit Anti-Thymocyte Globulin and Anti-CD20+ Monoclonal Antibody

    B. Gelb,1 J. Diaz-Siso,2 N. Plana,2 A. Jacoby,2 W. Rifkin,2 K. Khouri,2 D. Ceradini,2 E. Rodriguez.2

    1Transplant Institute, NYU Langone Health, New York, NY; 2Hansjörg Wyss Department of Plastic Surgery, NYU Langone Health, New York, NY.

    OBJECTIVE: Vascularized composite allograft (VCA) transplantation has become a feasible reconstructive option for patients with severe facial disfigurement. Short term patient and graft survival have…
  • 2018 American Transplant Congress

    The Impact of Rituximab Dose on Hepatitis B Virus Reactivation in HBsAg-Negative/anti-HBc-Positive Kidney Transplant Recipients

    J. Lee,1 J. Park,2 Y. Jung,1 D. Kim,1 J. Lee,1 S. Song,3 J. Lee,4 J. Lee,1 B. Kim,5 M. Kim,1 S. Kim,1 Y. Kim,1 K. Huh.1

    1Surgery, Yonsei University College of Medicine, Seoul, Korea; 2Internal Medicine (Gastroenterology), Yonsei University College of Medicine, Seoul, Korea; 3Surgery, Ewha Womans University, School of Medicine, Seoul, Korea; 4Surgery, CHA Bundang Medical Center, CHA University, Seongnam, Korea; 5Internal Medicine (Nephrology), Yonsei University College of Medicine, Seoul, Korea.

    Background: Hepatitis B virus (HBV) reactivation is well-recognized complication of rituximab. Although use of rituximab for sensitized patients continues to increase in kidney transplantation, the…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences